Home / Treatment Library / Hormone Optimization for Women
Personalized menopause and hormone care. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Private, individualized care begins by listening closely to your concerns, priorities and health goals.
Explore our physician-guided Total Woman Weight-Loss Program, created to coordinate medical screening, nutrition, body-composition goals, aesthetic support and women’s wellness.
Women’s hormone care evaluates symptoms, life stage, health history and goals. Menopausal hormone therapy is the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause for appropriate candidates, but the formulation, route and duration require individualized risk assessment.
Many healthy symptomatic women younger than 60 or within 10 years of menopause onset may have a favorable benefit-risk profile, but candidacy is individual. Age, uterus status, migraine, clotting, cancer and cardiovascular history change the plan.
Systemic hormone therapy may be unsuitable with unexplained vaginal bleeding, certain estrogen-sensitive cancers, prior blood clots, stroke, heart attack, liver disease or other contraindications. Evaluation and alternative options are required.
These are practical planning ranges, not promises. Your consultation determines the exact plan.
The provider reviews menstrual or menopause stage, symptoms, contraception needs, medical history and current medicines.
Testing is targeted; hormone levels are not always required to diagnose typical menopause. Preventive screening and bleeding history are checked.
If therapy is appropriate, route, dose, progesterone need, nonhormonal options and monitoring are discussed through shared decision-making.
Risk depends on age, timing, route, dose, duration and medical history. Systemic therapy may increase risks of blood clots, stroke, gallbladder disease and—depending on regimen and duration—breast cancer. Estrogen without adequate endometrial protection can increase uterine-cancer risk in a woman with a uterus.
Hormone care is not a pellet or lab-value sales protocol. Experienced supervision chooses the safest route, protects the endometrium when needed, evaluates abnormal bleeding and revisits benefit and risk over time.
Initial and follow-up consultations may be available in-office or by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to law and clinical appropriateness. Examination, imaging or labs may be required.
Pricing: Consultation required. Cost depends on visit type, testing, medication, monitoring and insurance or pharmacy coverage.
When a prescription or compounded preparation is clinically appropriate, the dispensing pharmacy, facility classification and current license status matter. Compounded medications are not FDA-approved drug products.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Hormone Optimization for Women—or an alternative—makes sense.
